)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Oncolytics Biotech
Oncolytics Biotech (ONCY) investor relations material
Oncolytics Biotech Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary1 Apr, 2026
Company overview and business model
Clinical-stage biopharmaceutical company focused on developing pelareorep, an intravenously delivered immunotherapeutic targeting RAS-mutated tumors and enhancing immune response against cancer.
Pelareorep is a proprietary reovirus isolate designed to improve tumor microenvironment and increase patient response to various oncology treatments, including chemotherapies and immunotherapies.
Recently completed a two-step redomestication, now incorporated in Nevada as of March 31, 2026.
Financial performance and metrics
The registration statement incorporates by reference the Annual Report on Form 10-K for the year ended December 31, 2025, and recent Current Reports on Form 8-K.
The most recent audit report includes an explanatory paragraph raising substantial doubt about the company's ability to continue as a going concern.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used as set forth in the applicable prospectus supplement for each offering.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oncolytics Biotech
- Net loss increased to $28.8M in 2025, with urgent need for new funding to sustain operations.ONCY
Q4 202530 Mar 2026 - Pelareorep delivers superior survival and response rates in GI cancers, targeting major unmet needs.ONCYCorporate presentation20 Mar 2026
- Pivotal data and regulatory filings for late-stage cancer programs are expected imminently.ONCYH.C. Wainwright 26th Annual Global Investment Conference 20243 Feb 2026
- Advanced pivotal trials for pelareorep in cancer, secured funding, and maintained strong cash position.ONCYQ2 20242 Feb 2026
- Pelareorep advances toward registration in breast and pancreatic cancers, with new trials and funding needs.ONCYCanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- Pelareorep shows significant survival benefit in breast cancer, advancing toward accelerated approval.ONCY2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- All resolutions, including corporate moves and the 2026 Incentive Plan, were approved by shareholders.ONCYAGM 202615 Jan 2026
- Pelareorep delivers strong clinical efficacy and safety in GI cancers, with broad market potential.ONCYInvestor presentation15 Jan 2026
- Pelareorep nearly doubled survival in breast cancer, advancing toward pivotal trials and partnerships.ONCYQ3 202415 Jan 2026
Next Oncolytics Biotech earnings date
Q1 202613 May, 2026
Oncolytics Biotech
Next Oncolytics Biotech earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage